Sept 10, 2025
The clinical trial of the LIVERATION project has now reached 158 randomized patients—a milestone that reflects the strength of collaboration, trust, and shared purpose behind this ambitious European effort.
Behind each number is a story: a person who has chosen to contribute to the future of liver cancer treatment. Their courage, along with the dedication of medical, scientific, and coordination teams, is what drives this project forward.
Every new participant brings us one step closer to our goal: reducing liver cancer recurrence after surgery and improving long-term outcomes for those facing this disease.
Thank you to everyone involved for turning collaboration into progress.
We keep moving forward.